Global and Japan Long-Acting Injectables Market Size, Status and Forecast 2020-2026

SKU ID : QYR-16357730 | Publishing Date : 02-Sep-2020 | No. of pages : 91

Request Sample

Pre-order Enquiry

Request Customization

Check Discounts

Request a free Sample

Detailed TOC of Global and Japan Long-Acting Injectables Market Size, Status and Forecast 2020-2026

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Long-Acting Injectables Market Size Growth Rate by Type: 2020 VS 2026
        1.2.2 Small and Middle Sized Molecule
        1.2.3 Large Sized Molecule
    1.3 Market by Application
        1.3.1 Global Long-Acting Injectables Market Share by Application: 2020 VS 2026
        1.3.2 Schizophrenia
        1.3.3 Other Psychotic Disorders
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Long-Acting Injectables Market Perspective (2015-2026)
    2.2 Global Long-Acting Injectables Growth Trends by Regions
        2.2.1 Long-Acting Injectables Market Size by Regions: 2015 VS 2020 VS 2026
        2.2.2 Long-Acting Injectables Historic Market Share by Regions (2015-2020)
        2.2.3 Long-Acting Injectables Forecasted Market Size by Regions (2021-2026)
    2.3 Industry Trends and Growth Strategy
        2.3.1 Market Trends
        2.3.2 Market Drivers
        2.3.3 Market Challenges
        2.3.4 Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Long-Acting Injectables Players by Market Size
        3.1.1 Global Top Long-Acting Injectables Players by Revenue (2015-2020)
        3.1.2 Global Long-Acting Injectables Revenue Market Share by Players (2015-2020)
    3.2 Global Long-Acting Injectables Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Long-Acting Injectables Revenue
    3.4 Global Long-Acting Injectables Market Concentration Ratio
        3.4.1 Global Long-Acting Injectables Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Long-Acting Injectables Revenue in 2019
    3.5 Key Players Long-Acting Injectables Area Served
    3.6 Key Players Long-Acting Injectables Product Solution and Service
    3.7 Date of Enter into Long-Acting Injectables Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Long-Acting Injectables Breakdown Data by Type (2015-2026)
    4.1 Global Long-Acting Injectables Historic Market Size by Type (2015-2020)
    4.2 Global Long-Acting Injectables Forecasted Market Size by Type (2021-2026)

5 Long-Acting Injectables Breakdown Data by Application (2015-2026)
    5.1 Global Long-Acting Injectables Historic Market Size by Application (2015-2020)
    5.2 Global Long-Acting Injectables Forecasted Market Size by Application (2021-2026)

6 North America
    6.1 North America Long-Acting Injectables Market Size (2015-2026)
    6.2 North America Long-Acting Injectables Market Size by Type (2015-2020)
    6.3 North America Long-Acting Injectables Market Size by Application (2015-2020)
    6.4 North America Long-Acting Injectables Market Size by Country (2015-2020)
        6.4.1 United States
        6.4.2 Canada

7 Europe
    7.1 Europe Long-Acting Injectables Market Size (2015-2026)
    7.2 Europe Long-Acting Injectables Market Size by Type (2015-2020)
    7.3 Europe Long-Acting Injectables Market Size by Application (2015-2020)
    7.4 Europe Long-Acting Injectables Market Size by Country (2015-2020)
        7.4.1 Germany
        7.4.2 France
        7.4.3 U.K.
        7.4.4 Italy
        7.4.5 Russia
        7.4.6 Nordic
        7.4.7 Rest of Europe

8 China
    8.1 China Long-Acting Injectables Market Size (2015-2026)
    8.2 China Long-Acting Injectables Market Size by Type (2015-2020)
    8.3 China Long-Acting Injectables Market Size by Application (2015-2020)
    8.4 China Long-Acting Injectables Market Size by Region (2015-2020)
        8.4.1 China
        8.4.2 Japan
        8.4.3 South Korea
        8.4.4 Southeast Asia
        8.4.5 India
        8.4.6 Australia
        8.4.7 Rest of Asia-Pacific

9 Japan
    9.1 Japan Long-Acting Injectables Market Size (2015-2026)
    9.2 Japan Long-Acting Injectables Market Size by Type (2015-2020)
    9.3 Japan Long-Acting Injectables Market Size by Application (2015-2020)
    9.4 Japan Long-Acting Injectables Market Size by Country (2015-2020)
        9.4.1 Mexico
        9.4.2 Brazil

10 Southeast Asia
    10.1 Southeast Asia Long-Acting Injectables Market Size (2015-2026)
    10.2 Southeast Asia Long-Acting Injectables Market Size by Type (2015-2020)
    10.3 Southeast Asia Long-Acting Injectables Market Size by Application (2015-2020)
    10.4 Southeast Asia Long-Acting Injectables Market Size by Country (2015-2020)
        10.4.1 Turkey
        10.4.2 Saudi Arabia
        10.4.3 UAE
        10.4.4 Rest of Middle East & Africa

11 Key Players Profiles
    11.1 Eli Lilly
        11.1.1 Eli Lilly Company Details
        11.1.2 Eli Lilly Business Overview
        11.1.3 Eli Lilly Long-Acting Injectables Introduction
        11.1.4 Eli Lilly Revenue in Long-Acting Injectables Business (2015-2020))
        11.1.5 Eli Lilly Recent Development
    11.2 Pfizer
        11.2.1 Pfizer Company Details
        11.2.2 Pfizer Business Overview
        11.2.3 Pfizer Long-Acting Injectables Introduction
        11.2.4 Pfizer Revenue in Long-Acting Injectables Business (2015-2020)
        11.2.5 Pfizer Recent Development
    11.3 GlaxoSmithKline
        11.3.1 GlaxoSmithKline Company Details
        11.3.2 GlaxoSmithKline Business Overview
        11.3.3 GlaxoSmithKline Long-Acting Injectables Introduction
        11.3.4 GlaxoSmithKline Revenue in Long-Acting Injectables Business (2015-2020)
        11.3.5 GlaxoSmithKline Recent Development
    11.4 Johnson & Johnson
        11.4.1 Johnson & Johnson Company Details
        11.4.2 Johnson & Johnson Business Overview
        11.4.3 Johnson & Johnson Long-Acting Injectables Introduction
        11.4.4 Johnson & Johnson Revenue in Long-Acting Injectables Business (2015-2020)
        11.4.5 Johnson & Johnson Recent Development
    11.5 Lupin Limited
        11.5.1 Lupin Limited Company Details
        11.5.2 Lupin Limited Business Overview
        11.5.3 Lupin Limited Long-Acting Injectables Introduction
        11.5.4 Lupin Limited Revenue in Long-Acting Injectables Business (2015-2020)
        11.5.5 Lupin Limited Recent Development
    11.6 Zogenix
        11.6.1 Zogenix Company Details
        11.6.2 Zogenix Business Overview
        11.6.3 Zogenix Long-Acting Injectables Introduction
        11.6.4 Zogenix Revenue in Long-Acting Injectables Business (2015-2020)
        11.6.5 Zogenix Recent Development
    11.7 DURECT
        11.7.1 DURECT Company Details
        11.7.2 DURECT Business Overview
        11.7.3 DURECT Long-Acting Injectables Introduction
        11.7.4 DURECT Revenue in Long-Acting Injectables Business (2015-2020)
        11.7.5 DURECT Recent Development
    11.8 Medincel
        11.8.1 Medincel Company Details
        11.8.2 Medincel Business Overview
        11.8.3 Medincel Long-Acting Injectables Introduction
        11.8.4 Medincel Revenue in Long-Acting Injectables Business (2015-2020)
        11.8.5 Medincel Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Figures, Tables and Charts Available in Global and Japan Long-Acting Injectables Market Size, Status and Forecast 2020-2026

List of Tables
    Table 1. Global Long-Acting Injectables Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
    Table 3. Key Players of Small and Middle Sized Molecule
    Table 4. Key Players of Large Sized Molecule
    Table 5. Global Long-Acting Injectables Market Size Growth by Application (US$ Million): 2020 VS 2026
    Table 6. Global Long-Acting Injectables Market Size by Regions (US$ Million): 2020 VS 2026
    Table 7. Global Long-Acting Injectables Market Size by Regions (2015-2020) (US$ Million)
    Table 8. Global Long-Acting Injectables Market Share by Regions (2015-2020)
    Table 9. Global Long-Acting Injectables Forecasted Market Size by Regions (2021-2026) (US$ Million)
    Table 10. Global Long-Acting Injectables Market Share by Regions (2021-2026)
    Table 11. Long-Acting Injectables Market Market Trends
    Table 12. Long-Acting Injectables Market Drivers
    Table 13. Long-Acting Injectables Market Challenges
    Table 14. Long-Acting Injectables Market Restraints
    Table 15. Global Long-Acting Injectables Revenue by Players (2015-2020) (US$ Million)
    Table 16. Global Long-Acting Injectables Market Share by Players (2015-2020)
    Table 17. Global Top Long-Acting Injectables Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Long-Acting Injectables as of 2019)
    Table 18. Global Long-Acting Injectables by Players Market Concentration Ratio (CR5 and HHI)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Long-Acting Injectables Product Solution and Service
    Table 21. Mergers & Acquisitions, Expansion Plans
    Table 22. Global Long-Acting Injectables Market Size by Type (2015-2020) (US$ Million)
    Table 23. Global Long-Acting Injectables Market Size Share by Type (2015-2020)
    Table 24. Global Long-Acting Injectables Revenue Market Share by Type (2021-2026)
    Table 25. Global Long-Acting Injectables Market Size Share by Application (2015-2020)
    Table 26. Global Long-Acting Injectables Market Size by Application (2015-2020) (US$ Million)
    Table 27. Global Long-Acting Injectables Market Size Share by Application (2021-2026)
    Table 28. North America Long-Acting Injectables Market Size by Type (2015-2020) (US$ Million)
    Table 29. North America Long-Acting Injectables Market Share by Type (2015-2020)
    Table 30. North America Long-Acting Injectables Market Size by Application (2015-2020) (US$ Million)
    Table 31. North America Long-Acting Injectables Market Share by Application (2015-2020)
    Table 32. North America Long-Acting Injectables Market Size by Country (US$ Million) (2015-2020)
    Table 33. North America Long-Acting Injectables Market Share by Country (2015-2020)
    Table 34. Europe Long-Acting Injectables Market Size by Type (2015-2020) (US$ Million)
    Table 35. Europe Long-Acting Injectables Market Share by Type (2015-2020)
    Table 36. Europe Long-Acting Injectables Market Size by Application (2015-2020) (US$ Million)
    Table 37. Europe Long-Acting Injectables Market Share by Application (2015-2020)
    Table 38. Europe Long-Acting Injectables Market Size by Country (US$ Million) (2015-2020)
    Table 39. Europe Long-Acting Injectables Market Share by Country (2015-2020)
    Table 40. China Long-Acting Injectables Market Size by Type (2015-2020) (US$ Million)
    Table 41. China Long-Acting Injectables Market Share by Type (2015-2020)
    Table 42. China Long-Acting Injectables Market Size by Application (2015-2020) (US$ Million)
    Table 43. China Long-Acting Injectables Market Share by Application (2015-2020)
    Table 44. China Long-Acting Injectables Market Size by Region (US$ Million) (2015-2020)
    Table 45. China Long-Acting Injectables Market Share by Region (2015-2020)
    Table 46. Japan Long-Acting Injectables Market Size by Type (2015-2020) (US$ Million)
    Table 47. Japan Long-Acting Injectables Market Share by Type (2015-2020)
    Table 48. Japan Long-Acting Injectables Market Size by Application (2015-2020) (US$ Million)
    Table 49. Japan Long-Acting Injectables Market Share by Application (2015-2020)
    Table 50. Japan Long-Acting Injectables Market Size by Country (US$ Million) (2015-2020)
    Table 51. Japan Long-Acting Injectables Market Share by Country (2015-2020)
    Table 52. Southeast Asia Long-Acting Injectables Market Size by Type (2015-2020) (US$ Million)
    Table 53. Southeast Asia Long-Acting Injectables Market Share by Type (2015-2020)
    Table 54. Southeast Asia Long-Acting Injectables Market Size by Application (2015-2020) (US$ Million)
    Table 55. Southeast Asia Long-Acting Injectables Market Share by Application (2015-2020)
    Table 56. Southeast Asia Long-Acting Injectables Market Size by Country (US$ Million) (2015-2020)
    Table 57. Southeast Asia Long-Acting Injectables Market Share by Country (2015-2020)
    Table 58. Eli Lilly Company Details
    Table 59. Eli Lilly Business Overview
    Table 60. Eli Lilly Product
    Table 61. Eli Lilly Revenue in Long-Acting Injectables Business (2015-2020) (US$ Million)
    Table 62. Eli Lilly Recent Development
    Table 63. Pfizer Company Details
    Table 64. Pfizer Business Overview
    Table 65. Pfizer Product
    Table 66. Pfizer Revenue in Long-Acting Injectables Business (2015-2020) (US$ Million)
    Table 67. Pfizer Recent Development
    Table 68. GlaxoSmithKline Company Details
    Table 69. GlaxoSmithKline Business Overview
    Table 70. GlaxoSmithKline Product
    Table 71. GlaxoSmithKline Revenue in Long-Acting Injectables Business (2015-2020) (US$ Million)
    Table 72. GlaxoSmithKline Recent Development
    Table 73. Johnson & Johnson Company Details
    Table 74. Johnson & Johnson Business Overview
    Table 75. Johnson & Johnson Product
    Table 76. Johnson & Johnson Revenue in Long-Acting Injectables Business (2015-2020) (US$ Million)
    Table 77. Johnson & Johnson Recent Development
    Table 78. Lupin Limited Company Details
    Table 79. Lupin Limited Business Overview
    Table 80. Lupin Limited Product
    Table 81. Lupin Limited Revenue in Long-Acting Injectables Business (2015-2020) (US$ Million)
    Table 82. Lupin Limited Recent Development
    Table 83. Zogenix Company Details
    Table 84. Zogenix Business Overview
    Table 85. Zogenix Product
    Table 86. Zogenix Revenue in Long-Acting Injectables Business (2015-2020) (US$ Million)
    Table 87. Zogenix Recent Development
    Table 88. DURECT Company Details
    Table 89. DURECT Business Overview
    Table 90. DURECT Product
    Table 91. DURECT Revenue in Long-Acting Injectables Business (2015-2020) (US$ Million)
    Table 92. DURECT Recent Development
    Table 93. Medincel Business Overview
    Table 94. Medincel Product
    Table 95. Medincel Company Details
    Table 96. Medincel Revenue in Long-Acting Injectables Business (2015-2020) (US$ Million)
    Table 97. Medincel Recent Development
    Table 98. Research Programs/Design for This Report
    Table 99. Key Data Information from Secondary Sources
    Table 100. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Long-Acting Injectables Market Share by Type: 2020 VS 2026
    Figure 2. Small and Middle Sized Molecule Features
    Figure 3. Large Sized Molecule Features
    Figure 4. Global Long-Acting Injectables Market Share by Application: 2020 VS 2026
    Figure 5. Schizophrenia Case Studies
    Figure 6. Other Psychotic Disorders Case Studies
    Figure 7. Long-Acting Injectables Report Years Considered
    Figure 8. Global Long-Acting Injectables Market Size (US$ Million), YoY Growth 2015-2026
    Figure 9. Global Long-Acting Injectables Market Share by Regions: 2020 VS 2026
    Figure 10. Global Long-Acting Injectables Market Share by Regions (2021-2026)
    Figure 11. Global Long-Acting Injectables Market Share by Players in 2019
    Figure 12. Global Top Long-Acting Injectables Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Long-Acting Injectables as of 2019
    Figure 13. The Top 10 and 5 Players Market Share by Long-Acting Injectables Revenue in 2019
    Figure 14. North America Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 15. United States Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 16. Canada Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 17. Europe Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 18. Germany Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 19. France Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 20. U.K. Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 21. Italy Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 22. Russia Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 23. Nordic Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 24. Rest of Europe Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 25. Asia-Pacific Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 26. China Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 27. Japan Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 28. South Korea Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 29. Southeast Asia Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 30. India Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 31. Australia Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 32. Rest of Asia-Pacific Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 33. Latin America Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 34. Mexico Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 35. Brazil Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 36. Middle East & Africa Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 37. Turkey Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 38. Saudi Arabia Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 39. UAE Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 40. Rest of Middle East & Africa Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 41. Eli Lilly Revenue Growth Rate in Long-Acting Injectables Business (2015-2020)
    Figure 42. Pfizer Revenue Growth Rate in Long-Acting Injectables Business (2015-2020)
    Figure 43. GlaxoSmithKline Revenue Growth Rate in Long-Acting Injectables Business (2015-2020)
    Figure 44. Johnson & Johnson Revenue Growth Rate in Long-Acting Injectables Business (2015-2020)
    Figure 45. Lupin Limited Revenue Growth Rate in Long-Acting Injectables Business (2015-2020)
    Figure 46. Zogenix Revenue Growth Rate in Long-Acting Injectables Business (2015-2020)
    Figure 47. DURECT Revenue Growth Rate in Long-Acting Injectables Business (2015-2020)
    Figure 48. Medincel Revenue Growth Rate in Long-Acting Injectables Business (2015-2020)
    Figure 49. Bottom-up and Top-down Approaches for This Report
    Figure 50. Data Triangulation
    Figure 51. Key Executives Interviewed

Keyplayers in Global and Japan Long-Acting Injectables Market Size, Status and Forecast 2020-2026

Eli Lilly
Pfizer
GlaxoSmithKline
Johnson & Johnson
Lupin Limited
Zogenix
DURECT
Medincel

Global and Japan Long-Acting Injectables Market Size, Status and Forecast 2020-2026

Detailed TOC of Global and Japan Long-Acting Injectables Market Size, Status and Forecast 2020-2026

List of Figures, Tables and Charts Available in Global and Japan Long-Acting Injectables Market Size, Status and Forecast 2020-2026

Keyplayers in Global and Japan Long-Acting Injectables Market Size, Status and Forecast 2020-2026

REQUEST SUMMARY

Our Clients